# LEAVE Safe With DOACs

> **NCT04068727** · NA · COMPLETED · sponsor: **University of Massachusetts, Worcester** · enrollment: 561 (actual)

## Conditions studied

- Cardiovascular Diseases
- Venous Thromboembolism
- Atrial Fibrillation
- Bleeding
- Stroke

## Interventions

- **OTHER:** Clinical Pharmacist Intervention

## Key facts

- **NCT ID:** NCT04068727
- **Lead sponsor:** University of Massachusetts, Worcester
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-02
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-09-14
- **Target enrollment:** 561 (ACTUAL)
- **Last updated:** 2024-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04068727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04068727, "LEAVE Safe With DOACs". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04068727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*